Celluminova Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$763K
- Investors
-
5
Celluminova General Information
Description
Developer of stem cell research tools designed to increase visibility and distribute the products generated from academic efforts. The company's research is designed for live detection and visualization of neural stem cells and progenitors derived using a system that illuminates in and specifically detects embryonic mammalian stem cells, enabling the healthcare industry to detect neural and glioma-derived progenitors in a more specific and sensitive manner.
Contact Information
Website
www.celluminova.seCorporate Office
- OBOE IPR
- Box 1891
- 581 18 Linkoping
- Sweden
Corporate Office
- OBOE IPR
- Box 1891
- 581 18 Linkoping
- Sweden
Celluminova Timeline
Celluminova Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 11-Nov-2024 | $763K | Completed | Generating Revenue | ||
| 4. Seed Round | 31-Dec-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 30-Mar-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 28-Jan-2020 | $591K | $591K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
Celluminova Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Celluminova Patents
Celluminova Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2011218486-A1 | Oligothiophene derivate as molecular probes | Active | 16-Feb-2010 | ||
| AU-2011218486-B2 | Oligothiophene derivate as molecular probes | Active | 16-Feb-2010 | ||
| CA-2789017-A1 | Oligothiophene derivate as molecular probes | Active | 16-Feb-2010 | ||
| CA-2789017-C | Oligothiophene derivate as molecular probes | Active | 16-Feb-2010 | ||
| EP-2536712-A1 | Oligothiophene derivate as molecular probes | Active | 16-Feb-2010 | C07D409/14 |
Celluminova Signals
Celluminova Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| STUNS Life Science | Accelerator/Incubator | |||
| Tillväxtverket | Government | |||
| Almi Invest | Venture Capital | Minority | ||
| LiU Invest | Venture Capital | Minority | ||
| LEAD Incubator | Accelerator/Incubator |
Celluminova FAQs
-
When was Celluminova founded?
Celluminova was founded in 2010.
-
Where is Celluminova headquartered?
Celluminova is headquartered in Linkoping, Sweden.
-
What is the size of Celluminova?
Celluminova has 9 total employees.
-
What industry is Celluminova in?
Celluminova’s primary industry is Discovery Tools (Healthcare).
-
Is Celluminova a private or public company?
Celluminova is a Private company.
-
What is the current valuation of Celluminova?
The current valuation of Celluminova is .
-
What is Celluminova’s current revenue?
The current revenue for Celluminova is .
-
How much funding has Celluminova raised over time?
Celluminova has raised $2.13M.
-
Who are Celluminova’s investors?
STUNS Life Science, Tillväxtverket, Almi Invest, LiU Invest, and LEAD Incubator have invested in Celluminova.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process